跳至主要内容
临床试验/NCT04948476
NCT04948476已完成不适用

Promoting Kidney Recovery After Acute Kidney Injury Receiving Dialysis

Samuel Silver2 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2022年4月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
110
试验地点
2
主要终点
Recruitment

研究概览

简要总结

The overall goal of this study is to evaluate the feasibility of conducting a randomized controlled trial comparing a standardized dialysis strategy versus usual care (dialysis prescription ordered by each patient's primary nephrologist) in patients with AKI-receiving dialysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Received ≥2 sessions of any dialysis modality for presumed AKI
  • Plans for continued intermittent hemodialysis or sustained low efficiency dialysis treatments

排除标准

  • Receipt of dialysis for ≥90 days
  • Known baseline estimated glomerular filtration rate (eGFR) <15mL/min/1.73m2
  • Strong clinical suspicion of urinary tract obstruction, rapidly progressive glomerulonephritis (RPGN), vasculitis, thrombotic microangiopathy (TMA), myeloma related cast nephropathy, or acute interstitial nephritis (AIN) as the underlying cause of AKI
  • Receipt of any dialysis prior to the current admission within the past 2 months
  • Kidney transplant within the past 12 months

结局指标

主要结局

Recruitment

时间窗: 2 years

Recruitment of the target population to the RCT

Fidelity

时间窗: 2 years

At least 80% of randomized participants remain in the trial and on the allocated study treatment

次要结局

  • Dialysis-Free Days(6-months)
  • Hypotensive Event on Dialysis(6-months)

研究者

发起方
Samuel Silver
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Samuel Silver

Dr. Samuel A Silver

Queen's University

研究点 (2)

Loading locations...

相似试验